Office of Research & Development |
  |
Talk to the Veterans Crisis Line now
An official website of the United States government
Project Number: | I01BX004660-01 |
| Title: | Pathogenic Role of Malondialdehyde-Acetaldehyde Adducts in Rheumatoid Arthritis |
| Principal Investigator: | Ted R. Mikuls |
| Location: | Omaha, NE |
| Congressional District Code: | 2 |
| Research Service: | Biomedical Laboratory R&D |
| Project Period: | October 2019 - September 2023 |
| FY 2021 Funding Amount: | $156,800 |
| Total Award Amount (all years): |
$705,000 |
| Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: It has been estimated that rheumatologist-diagnosed Rheumatoid arthritis (RA) is seen in up to 2% of the users of VA healthcare. Moreover, compared to RA in women, RA in men (the primary VA demographic) leads to greater morbidity, a higher frequency of extra-articular manifestations, and worse disease-related outcomes. With an aging and predominantly male veteran population, it is anticipated that the burden posed by RA will grow dramatically in the VA in coming years. This is highly relevant gi... |